Information updates

Primary immunodeficiency (PID) e-training

Mar 9, 2016: 
New e-training course online now. 

ASCIA primary immunodeficiency (PID) e-training for health professionals is now available free of charge from the ASCIA website: 

ASCIA primary immunodeficiency (PID) e-training for health professionals

The main objectives of this course are to:

  • Increase awareness of PID amongst general practitioners, paediatricians and general physicians.
  • Promote early recognition and referral to a clinical immunologist to improve management of patients with PID in Australia and New Zealand.

Content updated March 2016

Mod ASCIA Member
Donate to AIFA
go to NAS website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.